CNR1 and lung carcinoma: Some studies have confirmed that CBD inhibits PAI-1 expression in lung cancer A549 cells through a cannabinoid receptor 1 (cannabisreceptor1, CB1)/cannabinoid receptor 2 (cannabisreceptor2, CB2)/TRPV1-dependent pathway, which inhibits cell invasion.